Nanoparticles in radiation oncology: From bench-side to bedside

Cancer Letters

Volumn 375, Issue 2, 2016, Pages 256-262

  Rancoule, Chloé ^a   Magné, Nicolas ^a,b   Vallard, Alexis ^a   Guy, Jean Baptiste ^a,b   Rodriguez Lafrasse, Claire ^b,c   Deutsch, Eric ^d,e   Chargari, Cyrus ^d,f  

^a Lucien Neuwirth Cancer Institute   (France)

^b Albert Trillat Center   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d Radiotherapy Department   (France)

^e INSERM   (France)

^f INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

Author keywords

Clinical trials; Drug vector; Nanoparticles; Radio sensitizer; Radiotherapy

Indexed keywords

ALBUMIN; CAMPTOTHECIN; CARBON NANOTUBE; CARBOPLATIN; CISPLATIN; CYCLODEXTRIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ETANIDAZOLE; GADOLINIUM; GOLD NANOPARTICLE; HAFNIUM OXIDE NANOPARTICLE; NANOPARTICLE; PACLITAXEL; PLATINUM NANOPARTICLE; QUANTUM DOT; RADIOSENSITIZING AGENT; SILVER NANOPARTICLE; SURVIVIN; TRASTUZUMAB; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; CANCER INHIBITION; CANCER RADIOTHERAPY; CLEARANCE; COMPTON EFFECT; DNA DAMAGE; DRUG TRANSPORT; ENDOCYTOSIS; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; NANOTECHNOLOGY; NANOTOXICOLOGY; NON SMALL CELL LUNG CANCER; NONHUMAN; PARTICLE SIZE; PERMEABILITY; PRIORITY JOURNAL; RADIATION ABSORPTION; RECTUM CANCER; SHORT SURVEY; SOFT TISSUE SARCOMA; SOLID TUMOR; THERANOSTIC NANOMEDICINE; CHEMISTRY; DRUG DELIVERY SYSTEM; ONCOLOGY;

DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; RADIATION ONCOLOGY; RADIATION-SENSITIZING AGENTS; THERANOSTIC NANOMEDICINE;

EID: 84961233655     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.03.011     Document Type: Review

References (93)

1. Kwatra D., Venugopal A., Anant S. Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer. Transl. Cancer Res 2013, 2:330-342. 10.3978/j.issn.2218-676X.2013.08.06.
2. Babaei M., Ganjalikhani M. The potential effectiveness of nanoparticles as radio sensitizers for radiotherapy. Bioimpacts 2014, 4:15-20. 10.5681/bi.2014.003.
3. Calugaru V., Magné N., Hérault J., Bonvalot S., Le Tourneau C., Thariat J. [Nanoparticles and radiation therapy]. Bull. Cancer 2015, 102:83-91. 10.1016/j.bulcan.2014.10.002.
4. Hainfeld J.F., Slatkin D.N., Smilowitz H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol 2004, 49:N309-N315. 10.1088/0031-9155/49/18/N03.
5. Nie S., Xing Y., Kim G.J., Simons J.W. Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng 2007, 9:257-288. 10.1146/annurev.bioeng.9.060906.152025.
6. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 2000, 65:271-284. 10.1016/S0168-3659(99)00248-5.
7. Ruoslahti E., Bhatia S.N., Sailor M.J. Targeting of drugs and nanoparticles to tumors. J. Cell Biol 2010, 188:759-768. 10.1083/jcb.200910104.
8. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev 2004, 56:1649-1659. 10.1016/j.addr.2004.02.014.
9. Torchilin V.P. Passive and active drug targeting: drug delivery to tumors as an example. Handb. Exp. Pharmacol 2010, 3-53. 10.1007/978-3-642-00477-3_1.
10. Chattopadhyay N., Cai Z., Kwon Y.L., Lechtman E., Pignol J.-P., Reilly R.M. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res. Treat 2013, 137:81-91. 10.1007/s10549-012-2338-4.
11. Yang Y., Zhang L., Cai J., Li X., Cheng D., Su H., et al. Tumor angiogenesis targeted radiosensitization therapy using gold nanoprobes guided by MRI/SPECT imaging. ACS Appl. Mater. Interfaces 2016, 1718-1732. 10.1021/acsami.5b09274.
12. Chattopadhyay N., Fonge H., Cai Z., Scollard D., Lechtman E., Done S.J., et al. Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Mol. Pharm 2012, 9:2168-2179. 10.1021/mp300016p.
13. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond.) 2011, 6:715-728. 10.2217/nnm.11.19.
14. Adams F.H., Norman A., Mello R.S., Bass D. Effect of radiation and contrast media on chromosomes. Preliminary report. Radiology 1977, 124:823-826. 10.1148/124.3.823.
15. Roeske J.C., Nunez L., Hoggarth M., Labay E., Weichselbaum R.R. Characterization of the theorectical radiation dose enhancement from nanoparticles. Technol. Cancer Res. Treat 2007, 6:395-401. 10.1177/153303460700600504.
16. Geng F., Song K., Xing J.Z., Yuan C., Yan S., Yang Q., et al. Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer. Nanotechnology 2011, 22:285101. 10.1088/0957-4484/22/28/285101.
17. Coulter J.A., Jain S., Butterworth K.T., Taggart L.E., Dickson G.R., McMahon S.J., et al. Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. Int. J. Nanomedicine 2012, 7:2673-2685. 10.2147/IJN.S31751.
18. Roa W., Zhang X., Guo L., Shaw A., Hu X., Xiong Y., et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 2009, 20:375101-375110. 10.1088/0957-4484/20/37/375101.
19. Zhang X.-D., Wu D., Shen X., Chen J., Sun Y.-M., Liu P.-X., et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 2012, 33:6408-6419. 10.1016/j.biomaterials.2012.05.047.
20. Pan Y., Leifert A., Ruau D., Neuss S., Bornemann J., Schmid G., et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 2009, 5:2067-2076. 10.1002/smll.200900466.
21. Petrache Voicu S.N., Dinu D., Sima C., Hermenean A., Ardelean A., Codrici E., et al. Silica nanoparticles induce oxidative stress and autophagy but not apoptosis in the MRC-5 cell line. Int. J. Mol. Sci 2015, 16:29398-29416. 10.3390/ijms161226171.
22. Chang M.-Y., Shiau A.-L., Chen Y.-H., Chang C.-J., Chen H.H.-W., Wu C.-L. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci 2008, 99:1479-1484. 10.1111/j.1349-7006.2008.00827.x.
23. Maggiorella L., Barouch G., Devaux C., Pottier A., Deutsch E., Bourhis J., et al. Nanoscale radiotherapy with hafnium oxide nanoparticles. Future Oncol 2012, 8:1167-1181. 10.2217/fon.12.96.
24. Misawa M., Takahashi J. Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV irradiations. Nanomedicine 2011, 7:604-614. 10.1016/j.nano.2011.01.014.
25. Chompoosor A., Saha K., Ghosh P.S., Macarthy D.J., Miranda O.R., Zhu Z.-J., et al. The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles. Small 2010, 6:2246-2249. 10.1002/smll.201000463.
26. Li J.J., Hartono D., Ong C.-N., Bay B.-H., Yung L.-Y.L. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 2010, 31:5996-6003. 10.1016/j.biomaterials.2010.04.014.
27. Piryazev A.P., Azizova O.A., Aseichev A.V., Dudnik L.B., Sergienko V.I. Effect of gold nanoparticles on production of reactive oxygen species by human peripheral blood leukocytes stimulated with opsonized zymosan. Bull. Exp. Biol. Med 2013, 156:101-103. 10.1007/s10517-013-2288-9.
28. Mateo D., Morales P., Ávalos A., Haza A.I. Oxidative stress contributes to gold nanoparticle-induced cytotoxicity in human tumor cells. Toxicol. Mech. Methods 2014, 24:161-172. 10.3109/15376516.2013.869783.
29. Kunjachan S., Detappe A., Kumar R., Ireland T., Cameron L., Biancur D.E., et al. Nanoparticle mediated tumor vascular disruption: a novel strategy in radiation therapy. Nano Lett 2015, 15:7488-7496. 10.1021/acs.nanolett.5b03073.
30. Yao X., Huang C., Chen X., Yi Z., Sanche L. Chemical radiosensitivity of DNA induced by gold nanoparticles. J. Biomed. Nanotechnol 2015, 11:478-485. 10.1166/jbn.2015.1922.
31. Butterworth K.T., Wyer J.A., Brennan-Fournet M., Latimer C.J., Shah M.B., Currell F.J., et al. Variation of strand break yield for plasmid DNA irradiated with high-Z metal nanoparticles. Radiat. Res 2008, 170:381-387. 10.1667/RR1320.1.
32. Brun E., Sanche L., Sicard-Roselli C. Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution. Colloids Surf. B. Biointerfaces 2009, 72:128-134. 10.1016/j.colsurfb.2009.03.025.
33. Hossain M., Luo Y., Sun Z., Wang C., Zhang M., Fu H., et al. X-ray enabled detection and eradication of circulating tumor cells with nanoparticles. Biosens. Bioelectron 2012, 38:348-354. 10.1016/j.bios.2012.06.020.
34. Ngwa W., Korideck H., Kassis A.I., Kumar R., Sridhar S., Makrigiorgos G.M., et al. In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomedicine 2013, 9:25-27. 10.1016/j.nano.2012.09.001.
35. Lechtman E., Chattopadhyay N., Cai Z., Mashouf S., Reilly R., Pignol J.P. Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys. Med. Biol 2011, 56:4631-4647. 10.1088/0031-9155/56/15/001.
36. Alqathami M., Blencowe A., Yeo U.J., Doran S.J., Qiao G., Geso M. Novel multicompartment 3-dimensional radiochromic radiation dosimeters for nanoparticle-enhanced radiation therapy dosimetry. Int. J. Radiat. Oncol. Biol. Phys 2012, 84:e549-e555. 10.1016/j.ijrobp.2012.05.029.
37. Joh D.Y., Sun L., Stangl M., Al Zaki A., Murty S., Santoiemma P.P., et al. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS ONE 2013, 8:e62425. 10.1371/journal.pone.0062425.
38. Young S.W., Qing F., Harriman A., Sessler J.L., Dow W.C., Mody T.D., et al. Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:6610-6615. 10.1073/pnas.93.13.6610.
39. Rima W., Sancey L., Aloy M.-T., Armandy E., Alcantara G.B., Epicier T., et al. Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials 2013, 34:181-195. 10.1016/j.biomaterials.2012.09.029.
40. Mowat P., Mignot A., Rima W., Lux F., Tillement O., Roulin C., et al. In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells. J. Nanosci. Nanotechnol 2011, 11:7833-7839. 10.1166/jnn.2011.4725.
41. Le Duc G., Miladi I., Alric C., Mowat P., Bräuer-Krisch E., Bouchet A., et al. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano 2011, 5:9566-9574. 10.1021/nn202797h.
42. Miladi I., Aloy M.-T., Armandy E., Mowat P., Kryza D., Magné N., et al. Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma. Nanomedicine 2015, 11:247-257. 10.1016/j.nano.2014.06.013.
43. Tokumitsu H., Hiratsuka J., Sakurai Y., Kobayashi T., Ichikawa H., Fukumori Y. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett 2000, 150:177-182. 10.1016/S0304-3835(99)00388-2.
44. Ma J., Xu R., Sun J., Zhao D., Tong J., Sun X. Nanoparticle surface and nanocore properties determine the effect on radiosensitivity of cancer cells upon ionizing radiation treatment. J. Nanosci. Nanotechnol 2013, 13:1472-1475. http://dx.doi.org/10.1166/jnn.2013.6087.
45. Liu P., Huang Z., Chen Z., Xu R., Wu H., Zang F., et al. Silver nanoparticles: a novel radiation sensitizer for glioma?. Nanoscale 2013, 5:11829-11836. 10.1039/c3nr01351k.
46. Porcel E., Liehn S., Remita H., Usami N., Kobayashi K., Furusawa Y., et al. Platinum nanoparticles: a promising material for future cancer therapy?. Nanotechnology 2010, 21:85103-85110. 10.1088/0957-4484/21/8/085103.
47. Mendoza J.G., Frutis M.A.A., Flores G.A., Hipólito M.G., Maciel Cerda A., Azorín Nieto J., et al. Synthesis and characterization of hafnium oxide films for thermo and photoluminescence applications. Appl. Radiat. Isot 2010, 68:696-699. 10.1016/j.apradiso.2009.09.031.
48. Juzenas P., Chen W., Sun Y.-P., Coelho M.A.N., Generalov R., Generalova N., et al. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug Deliv. Rev 2008, 60:1600-1614. 10.1016/j.addr.2008.08.004.
49. Wang Y.H., Chen Z., Zhou X.Q. Synthesis and photoluminescence of ZnS quantum dots. J. Nanosci. Nanotechnol 2008, 8:1312-1315. 10.1016/j.solidstatesciences.2011.12.005.
50. Chatterjee D.K., Fong L.S., Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliv. Rev 2008, 60:1627-1637. 10.1016/j.addr.2008.08.003.
51. Karimi M., Solati N., Ghasemi A., Estiar M.A., Hashemkhani M., Kiani P., et al. Carbon nanotubes part II: a remarkable carrier for drug and gene delivery. Expert Opin. Drug Deliv 2015, 12:1089-1105. 10.1517/17425247.2015.1004309.
52. Gong H., Peng R., Liu Z. Carbon nanotubes for biomedical imaging: the recent advances. Adv. Drug Deliv. Rev 2013, 65:1951-1963. 10.1016/j.addr.2013.10.002.
53. Prato M., Kostarelos K., Bianco A. Functionalized carbon nanotubes in drug design and discovery. Acc. Chem. Res 2008, 41:60-68. 10.1021/ar700089b.
54. Kostarelos K., Bianco A., Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol 2009, 4:627-633. 10.1038/nnano.2009.241.
55. Dineshkumar B., Krishnakumar K., Bhatt A.R., Paul D., Cherian J., John A., et al. Single-walled and multi-walled carbon nanotubes based drug delivery system: cancer therapy: a review. Indian J. Cancer 2015, 52:262-264. 10.4103/0019-509X.176720.
56. Chakrabarti M., Kiseleva R., Vertegel A., Ray S.K. Carbon nanomaterials for drug delivery and cancer therapy. J. Nanosci. Nanotechnol 2015, 15:5501-5511. http://dx.doi.org/10.1166/jnn.2015.10614.
57. Kostarelos K. The long and short of carbon nanotube toxicity. Nat. Biotechnol 2008, 26:774-776. 10.1038/nbt0708-774.
58. Dumortier H., Lacotte S., Pastorin G., Marega R., Wu W., Bonifazi D., et al. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett 2006, 6:1522-1528. 10.1021/nl061160x.
59. Soleyman R., Hirbod S., Adeli M. Advances in the biomedical application of polymer-functionalized carbon nanotubes. Biomater. Sci 2015, 3:695-711. 10.1039/c4bm00421c.
60. Karousis N., Tagmatarchis N., Tasis D. Current progress on the chemical modification of carbon nanotubes. Chem. Rev 2010, 110:5366-5397. 10.1021/cr100018g.
61. Gupta A.K., Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 2005, 26:1565-1573. 10.1016/j.biomaterials.2004.05.022.
62. Mitragotri S., Lahann J. Physical approaches to biomaterial design. Nat. Mater 2009, 8:15-23. 10.1038/nmat2344.
63. Wang J., Byrne J.D., Napier M.E., DeSimone J.M. More effective nanomedicines through particle design. Small 2011, 7:1919-1931. 10.1002/smll.201100442.
64. Chithrani D.B., Jelveh S., Jalali F., van Prooijen M., Allen C., Bristow R.G., et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat. Res 2010, 173:719-728. 10.1667/RR1984.1.
65. Sykes E.A., Dai Q., Sarsons C.D., Chen J., Rocheleau J.V., Hwang D.M., et al. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc. Natl. Acad. Sci. U. S. A. 2016, 113:E1142-E1151. 10.1073/pnas.1521265113.
66. Muro S., Garnacho C., Champion J.A., Leferovich J., Gajewski C., Schuchman E.H., et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther 2008, 16:1450-1458. 10.1038/mt.2008.127.
67. Patel S., Bhirde A.A., Rusling J.F., Chen X., Gutkind J.S., Patel V. Nano delivers big: designing molecular missiles for cancer therapeutics. Pharmaceutics 2011, 3:34-52. 10.3390/pharmaceutics3010034.
68. Petros R.A., DeSimone J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov 2010, 9:615-627. 10.1038/nrd2591.
69. He C., Lu J., Lin W. Hybrid nanoparticles for combination therapy of cancer. J. Control. Release 2015, 219:224-236. 10.1016/j.jconrel.2015.09.029.
70. Jin C., Bai L., Wu H., Tian F., Guo G. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro. Biomaterials 2007, 28:3724-3730. 10.1016/j.biomaterials.2007.04.032.
71. Werner M.E., Cummings N.D., Sethi M., Wang E.C., Sukumar R., Moore D.T., et al. Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys 2013, 86:463-468. 10.1016/j.ijrobp.2013.02.009.
72. Xu W.-H., Han M., Dong Q., Fu Z.-X., Diao Y.-Y., Liu H., et al. Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation. Int. J. Nanomedicine 2012, 7:2661-2671. 10.2147/IJN.S30445.
73. He L., Lai H., Chen T. Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathways. Biomaterials 2015, 51:30-42. 10.1016/j.biomaterials.2015.01.063.
74. Johnson J.L.H., Leos R.A., Baker A.F., Unger E.C. Radiosensitization of Hs-766T pancreatic tumor xenografts in mice dosed with dodecafluoropentane nano-emulsion-preliminary findings. J. Biomed. Nanotechnol 2015, 11:274-281. 10.1166/jbn.2015.1903.
75. Gaca S., Reichert S., Rödel C., Rödel F., Kreuter J. Survivin-miRNA-loaded nanoparticles as auxiliary tools for radiation therapy: preparation, characterisation, drug release, cytotoxicity and therapeutic effect on colorectal cancer cells. J. Microencapsul 2012, 29:685-694. 10.3109/02652048.2012.680511.
76. Zheng Y., Sanche L. Gold nanoparticles enhance DNA damage induced by anti-cancer drugs and radiation. Radiat. Res 2009, 172:114-119. 10.1667/RR1689.1.
77. Jeong S.-Y., Park S.-J., Yoon S.M., Jung J., Woo H.N., Yi S.L., et al. Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization. J. Control. Release 2009, 139:239-245. 10.1016/j.jconrel.2009.07.007.
78. Chen F., Zhang X.H., Hu X.D., Zhang W., Lou Z.C., Xie L.H., et al. Enhancement of radiotherapy by ceria nanoparticles modified with neogambogic acid in breast cancer cells. Int. J. Nanomedicine 2015, 10:4957-4969. 10.2147/IJN.S82980.
79. Puntes V. Design and pharmacokinetical aspects for the use of inorganic nanoparticles in radiomedicine. Br. J. Radiol 2015, 20150210. 10.1259/bjr.20150210.
80. Yao J., Hsu C.-H., Li Z., Kim T.S., Hwang L.-P., Lin Y.-C., et al. Magnetic resonance nano-theranostics for glioblastoma multiforme. Curr. Pharm. Des 2015, 21:5256-5266. 10.2174/1381612821666150923103307.
81. Lux F., Sancey L., Bianchi A., Crémillieux Y., Roux S., Tillement O. Gadolinium-based nanoparticles for theranostic MRI-radiosensitization. Nanomedicine (Lond.) 2015, 10:1801-1815. 10.2217/nnm.15.30.
82. Dufort S., Bianchi A., Henry M., Lux F., Le Duc G., Josserand V., et al. Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization. Small 2015, 11:215-221. 10.1002/smll.201401284.
83. Botchway S.W., Coulter J.A., Currell F.J. Imaging intracellular and systemic in vivo gold nanoparticles to enhance radiotherapy. Br. J. Radiol 2015, 88:20150170. 10.1259/bjr.20150170.
84. Wang Y., Liang R., Fang F. Applications of nanomaterials in radiotherapy for malignant tumors. J. Nanosci. Nanotechnol 2015, 15:5487-5500. 10.1166/jnn.2015.10617.
85. Sancey L., Lux F., Kotb S., Roux S., Dufort S., Bianchi A., et al. The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br. J. Radiol 2014, 87:20140134. 10.1259/bjr.20140134.
86. Lewis M.R., Kannan R. Development and applications of radioactive nanoparticles for imaging of biological systems. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol 2014, 6:628-640. 10.1002/wnan.1292.
87. McQuade C., Al Zaki A., Desai Y., Vido M., Sakhuja T., Cheng Z., et al. A multifunctional nanoplatform for imaging, radiotherapy, and the prediction of therapeutic response. Small 2015, 11:834-843. 10.1002/smll.201401927.
88. Bonvalot S., Le Pechoux C., De Baere T., Buy X., Italiano A., Stockle E., et al. Phase I study of NBTXR3 nanoparticles, in patients with advanced soft tissue sarcoma (STS) J. Clin. Oncol. (n.d.), accessed 08.01.2016. http://meetinglibrary.asco.org/content/127447-144.
89. Lammers P.E., Lu B., Horn L., Shyr Y., Keedy V. nab-paclitaxel in combination with weekly carboplatin with concurrent radiotherapy in stage III non-small cell lung cancer. Oncologist 2015, 20:491-492. 10.1634/theoncologist.2015-0030.
90. Sadauskas E., Danscher G., Stoltenberg M., Vogel U., Larsen A., Wallin H. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 2009, 5:162-169. 10.1016/j.nano.2008.11.002.
91. Soenen S.J., Manshian B., Montenegro J.M., Amin F., Meermann B., Thiron T., et al. Cytotoxic effects of gold nanoparticles: a multiparametric study. ACS Nano 2012, 6:5767-5783. 10.1021/nn301714n.
92. Zhang X.-D., Guo M.-L., Wu H.-Y., Sun Y.-M., Ding Y.-Q., Feng X., et al. Irradiation stability and cytotoxicity of gold nanoparticles for radiotherapy. Int. J. Nanomedicine 2009, 4:165-173. http://dx.doi.org/10.2147/IJN.S6723.
93. Schuemann J., Berbeco R., Chithrani D.B., Cho S.H., Kumar R., McMahon S.J., et al. Roadmap to clinical use of gold nanoparticles for radiation sensitization. Int. J. Radiat. Oncol. Biol. Phys 2016, 94:189-205. 10.1016/j.ijrobp.2015.09.032.